Finally, the incubation of human lung microvascular ECs with HA isolated from the plasma of COVID-19 patients, promoted endothelial barrier dysfunction in a CD44-depedent manner (Queisser et al. 2021). The gene discussed is CD44; the disease is COVID-19.